Literature DB >> 20653909

Serotonin-transporter-linked promoter region polymorphism and serotonin transporter binding in drug-naïve patients with major depression.

Mikko Joensuu1, Soili Marianne Lehto, Tommi Tolmunen, Pirjo Irmeli Saarinen, Minna Valkonen-Korhonen, Ritva Vanninen, Pasi Ahola, Jari Tiihonen, Jyrki Kuikka, Ullamari Pesonen, Johannes Lehtonen.   

Abstract

AIMS: Both the serotonin transporter and its genetic regulation by the serotonin-transporter-linked polymorphic region have a role in the pathophysiology of depression. Most of the previous studies have found no influence of serotonin-transporter-linked polymorphic region allelic variation on serotonin transporter binding in healthy controls or patients with major depression. Due to the inconsistency of the previous findings, we compared single photon emission computed tomography imaging with the serotonin-transporter-linked polymorphic region genotype in patients with major depressive disorder.
METHODS: A total of 23 drug-naïve patients with major depressive disorder were genotyped and brain imaged with ([123I])nor-beta-CIT single photon emission computed tomography. The severity of depression was evaluated with the 17-item Hamilton depression rating scale.
RESULTS: Depressed patients homozygous for the short allele had lower ([123I])nor-beta-CIT binding in the medial prefrontal cortex, but not in the midbrain, compared with the other genotypes.
CONCLUSION: The decreased medial prefrontal cortical serotonin transporter binding in the patients homozygous for the short allele may be linked to altered function of the serotonin-transporter-linked polymorphic region gene expressed in these patients, especially in the medial prefrontal cortex.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20653909     DOI: 10.1111/j.1440-1819.2010.02111.x

Source DB:  PubMed          Journal:  Psychiatry Clin Neurosci        ISSN: 1323-1316            Impact factor:   5.188


  6 in total

Review 1.  Endophenotypes as a measure of suicidality.

Authors:  Dimitry A Chistiakov; Zurab I Kekelidze; Vladimir P Chekhonin
Journal:  J Appl Genet       Date:  2012-09-02       Impact factor: 3.240

2.  Low brain serotonin transporter binding in major depressive disorder.

Authors:  Andrew B Newberg; Jay D Amsterdam; Nancy Wintering; Justine Shults
Journal:  Psychiatry Res       Date:  2012-06-12       Impact factor: 3.222

3.  Change over time in brain serotonin transporter binding in major depression: effects of therapy measured with [(123) I]-ADAM SPECT.

Authors:  Jay D Amsterdam; Andrew B Newberg; Cory F Newman; Justine Shults; Nancy Wintering; Irene Soeller
Journal:  J Neuroimaging       Date:  2013-06-10       Impact factor: 2.486

Review 4.  Disentangling the Neural Basis of Cognitive Behavioral Therapy in Psychiatric Disorders: A Focus on Depression.

Authors:  Moussa A Chalah; Samar S Ayache
Journal:  Brain Sci       Date:  2018-08-09

Review 5.  The Emerging Role of SPECT Functional Neuroimaging in Schizophrenia and Depression.

Authors:  Anil Kalyoncu; Ali Saffet Gonul
Journal:  Front Psychiatry       Date:  2021-12-15       Impact factor: 4.157

6.  123I-ADAM SPET imaging of serotonin transporter in patients with epilepsy and comorbid depression.

Authors:  Maarika Liik; Malle Paris; Liina Vahter; Katrin Gross-Paju; Sulev Haldre
Journal:  BMC Neurol       Date:  2013-12-17       Impact factor: 2.474

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.